PunjiPUNJI
Live AI ↗
Pharmaceuticals & BiotechnologyMid Cap

Laurus Labs Limited

LAURUSLABS · ISIN: INE947Q01028

Constituent of NIFTY 500 TRI (0.35%), NIFTY LMC 250 TRI (0.85%), NIFTY MC 150 TRI (1.69%), NIFTY SC 250 TRI (2.19%)

Close (as of 2026-09-08)
₹1946.9
+3.74% today
Day Range
₹1862.7 - ₹1952
Quality Score (as of 2026-06-30)
54.5/100

Earnings (TTM)

CHART

Laurus Labs Limited - revenue & profit (TTM)

Trailing-twelve-month figures by reported quarter, in ₹ Cr. Latest quarter: 2026-06-30.

0 Cr203550 Cr407100 Cr610650 Cr814200 CrQ2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Revenue (TTM)PAT (TTM)

22.02%

EBITDA Margin (TTM)

20.26

EPS (TTM)

0.78%

EPS Growth (5Y)

-

EPS Growth (10Y)

Technicals

66.9

RSI (14)

1732.3

SMA (50)

1275.32

SMA (200)

30.69

ADX (14)

1952

52-Week High

823.1

52-Week Low

126.36%

1Y Return

657.4046

Avg Traded Value (20D, ₹Cr)

As of 2026-09-08.

Shareholding Pattern

CHART

Shareholding by category

As of 2026-06-30.

27.47%72.53%TOP 2100%
Promoter 27.47%Public 72.53%

F&O Sentiment

Nearest expiry: 2026-09-29 · As of 2026-09-07.

0.6497

PCR (OI)

0.4939

PCR (Volume)

1840

Max Pain Strike

Corporate Actions

Ex-DateTypeRatioDetails
2020-09-29SPLIT0.200000 FACE VALUE SPLIT (SUB-DIVISION) - FROM RS 10/- PER SHARE TO RS 2/- PER SHARE

Recent Deals

No recent block/bulk/short-sell deals on record for this stock.

Stock data · Not financial advice · Past performance does not indicate future returns